Man Group PLC Paratek Pharmaceuticals, Inc. Transaction History

Man Group PLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$2.97 - $5.22 $41,654 - $73,210	-14,025 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$2.67 - $4.97 $37,446 - $69,704	14,025 New	14,025 $44,000
Q4 2018 Feb 14, 2019	SELL	$4.8 - $11.6 $995,054 - $2.4 Million	-207,303 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$9.05 - $10.95 $2.43 Million - $2.94 Million	-268,078 Reduced 56.39%	207,303 $2.01 Million
Q2 2018 Aug 14, 2018	SELL	$10.2 - $13.9 $728,708 - $993,043	-71,442 Reduced 13.06%	475,381 $4.85 Million
Q1 2018 May 15, 2018	BUY	$12.65 - $18.85 $6.92 Million - $10.3 Million	546,823 New	546,823 $7.11 Million

1.54M

Ticker PRTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,862,500
Description
Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectru...

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

Stay updated on Man Group PLC with notifications on news.